A carregar...
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis
BACKGROUND: Testing to determine HER2 status has come into focus since the approval of trastuzumab (Herceptin) for the treatment of HER2-positive breast cancer. We compared the cost-effectiveness of various strategies used to test HER2 status, an important first step toward evaluating the overall co...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Canadian Medical Association
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1863543/ https://ncbi.nlm.nih.gov/pubmed/17485695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.061011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|